Our purpose is to efficiently enable scientific breakthroughs by serving life scientists to achieve their mission, faster.
Our vision is to become the most influential life sciences company for researchers worldwide to support research, diagnostic and therapeutic applications.
We envision a world in which all life scientists have access to the precise tools and solutions they need to accurately advance their research, resulting in faster breakthroughs in scientific understanding, and an accelerated transition of those breakthroughs into clinical applications. This, we believe, will ultimately lead to improved diagnoses, treatments and human health and wellbeing.
At least one Abcam product is cited in over half of all life science papers (CiteAb, 2019)
antibodies validated for use on third-party platforms or for diagnostic use
custom products developed with our partners
products FDA approved, or in trials for a clinical or diagnostic application through partners
Every year around 750,000 life science researchers depend on our products and technical support. Located in over 130 countries, our customers work in academia, research institutes, and pharmaceutical, biotechnology and diagnostics companies. Together with high performance products, we provide expert customer support and rapid delivery, enabling our customers to reach their goals and achieve their mission, faster.
life science researchers
We are at the forefront of providing sustainable and reliable proteomic tools to the life science community. Our portfolio of off-the-shelf products and customized solutions are designed to perform consistently – first time, every time.
Our award-winning validated antibodies help scientists to save time and valuable resources, ensuring reproducible results and reliable scientific insights.
The need for new research tools is constant as users deepen scientific understanding and search for the next breakthrough. Driven to support their evolving needs, we continuously innovate, enhancing our in-house technical expertise and manufacturing capabilities to provide solutions that will enable scientific progress.
We are building partnerships across the life science community to co-create precision tools and novel reagents at a scale for use in drug discovery, in vitro diagnostics and therapeutic development. Leveraging our proprietary platforms and world-leading expertise, together with a flexible commercial approach we are passionate about collaborating to provide our partners with solutions and support to fast track their success.
As a dynamic life science company, we want to take part in building the future and making life better for people all over the world. Together with impactful, ethical product innovation, we concentrate our sustainability efforts in the most important areas – providing a rewarding workplace for our teams, building long-term partnerships, engaging in the communities we work in and minimizing our environmental footprint.
Our strategy is designed to increase our positive impact on science and society and sustain profitable growth, generating long-term value for our shareholders and stakeholders.
Our talented team of over 1,500 colleagues around the world is our single biggest asset. By applying our expertise and constantly pushing boundaries, we strive to be the best in everything we do – delivering innovative solutions that are enabling global scientific and clinical breakthroughs, faster.
Nurturing employee excellence is key to our success and we invest in continuous learning, training and development of staff.
Abcam is a global life sciences company providing highly validated antibodies and biological tools to the life scientist community. The success of our customers’ work, from basic research to translational science, diagnostics and therapeutic clinical programmes, relies on rigorous product quality, performance and reliability.
Operating transparently and responsibly, we manage our business to generate attractive and sustainable long-term economic returns and value for all our stakeholders.
Long-term industry forces across our markets remain attractive, with increases in research funding and capital investment supporting the growth of collaborative and global discovery networks.
Abcam’s goal is to create sustainable social and financial value, by helping accelerate the pace of discovery, and the translation of those discoveries into social impact. We are uniformly committed to responsibly pursuing that goal through our purpose and have a clear strategy to achieve this.
We have a highly experienced Board and Senior Executive Team. The Board is responsible for the Group’s corporate governance, sets the Group’s strategy and policies, has overall responsibility for the oversight of risk and also monitors progress towards meeting its strategic objectives and annual plans. The Board discharges these responsibilities through a programme of meetings and also assesses whether or not, and to what extent, its obligations to the Company’s shareholders and other stakeholders are understood and met. This includes regular reviews of the Group’s financial performance and critical business issues.
Abcam’s American Depositary Receipt (‘ADR’) Programme.
The Board believes that good governance is fundamental to the successful growth of our business.
Stay up to date with investor email alerts.